← back to search

Mathieu Anheim

Institut de Biologie Moléculaire et Cellulaire · FR
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Genetic Neurodegenerative Diseases, Parkinson's Disease Mechanisms and Treatments, Mitochondrial Function and Pathology, and Neurological disorders and treatments.
h-index
59
citations
16,224
works
373
NIH funding
primary concept
Medicine
email

Recent publications

Missense Variants in the A Isoform of FGF13 as a Novel Cause of Paroxysmal Dyskinesia.
2026cited by 0position: contributordoi
Managing Aminotransferase Elevations in Patients with Friedreich Ataxia Treated with Omaveloxolone: A Review and Expert Opinion on Use Considerations
Neurology and Therapy 2025cited by 9position: middledoi
The Spectrum of Neurologic Phenotypes Associated With <scp><i>NUS1</i></scp> Pathogenic Variants: A Comprehensive Case Series
Annals of Neurology 2025cited by 6position: middledoi
Managing Aminotransferase Elevations in Patients with Friedreich Ataxia Treated with Omaveloxolone: A Review and Expert Opinion on Use Considerations.
2025cited by 4position: contributordoi
Progress and challenges in sporadic late-onset cerebellar ataxias.
2025cited by 2position: contributordoi
A clinical and genotype-phenotype analysis of MACF1 variants
The American Journal of Human Genetics 2025cited by 1position: middledoi
The Two Faces of Pediatric <scp>SCA2</scp>
European Journal of Neurology 2025cited by 1position: middledoi
Trigeminal Tract Abnormality Leading to Leukodystrophy With Brainstem and Spinal Cord Involvement and High Lactate Diagnosis.
2025cited by 0position: contributordoi
Biallelic NAA60 variants with impaired N-terminal acetylation capacity cause autosomal recessive primary familial brain calcifications
Nature Communications 2024cited by 43position: middledoi
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies
Journal of Parkinson s Disease 2024cited by 14position: middledoi
Prognosis of impulse control disorders in Parkinson’s disease: a prospective controlled study
Journal of Neurology 2024cited by 5position: lastdoi
Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions
EBioMedicine 2023cited by 54position: middledoi
The inherited cerebellar ataxias: an update.
2023cited by 47position: contributordoi
Responsiveness of the Scale for the Assessment and Rating of Ataxia and Natural History in 884 Recessive and Early Onset Ataxia Patients
Annals of Neurology 2023cited by 35position: middledoi
Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias
The American Journal of Human Genetics 2023cited by 31position: middledoi
Autosomal Recessive Cerebellar Ataxias in Europe: Frequency, Onset, and Severity in 677 Patients
Movement Disorders 2023cited by 24position: middledoi
Consensus Recommendations for Clinical Outcome Assessments and Registry Development in Ataxias: Ataxia Global Initiative (AGI) Working Group Expert Guidance
The Cerebellum 2023cited by 20position: middledoi
Cerebral perfusion using ASL in patients with COVID-19 and neurological manifestations: A retrospective multicenter observational study
Journal of Neuroradiology 2023cited by 20position: middledoi
Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial
Journal of Neurology 2023cited by 15position: middledoi
Implementation of a Magnetic Resonance Imaging scanner dedicated to emergencies in cases of binocular diplopia: Impact on patient management.
2023cited by 2position: contributordoi
Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia.
2022cited by 59position: contributordoi
Efficacy of Caffeine in <scp>ADCY5</scp>‐Related Dyskinesia: A Retrospective Study
Movement Disorders 2022cited by 54position: middledoi
Limbic Stimulation Drives Mania in <scp>STN‐DBS</scp> in Parkinson Disease: A Prospective Study
Annals of Neurology 2022cited by 30position: middledoi
A Homozygous Missense Variant in PPP1R1B/DARPP-32 Is Associated With Generalized Complex Dystonia.
2022cited by 12position: contributordoi
Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson's Disease (PSYCHO-STIM II).
2022cited by 9position: contributordoi
Progression of Nigrostriatal Denervation in Cerebellar Multiple System Atrophy: A Prospective Study.
2022cited by 7position: contributordoi
"Phalanx sign" helps to discriminate MSA-C from idiopathic late onset cerebellar ataxia.
2022cited by 1position: contributordoi
Author Response: Progression of Nigrostriatal Denervation in Cerebellar Multiple System Atrophy: A Prospective Study.
2022cited by 0position: contributordoi
Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 Disease.
2021cited by 118position: contributordoi
Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia
Brain 2021cited by 68position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 11 papers (2020–2026)Thomas Wirth · Sorbonne Université9 papers (2020–2026)Gabrielle Rudolf · Centre National de la Recherche Scientifique7 papers (2019–2021)Christine Tranchant · Centre National de la Recherche Scientifique7 papers (2013–2022)Alexis Brice · Methodist Dallas Medical Center6 papers (2019–2020)Ludger Schoels · STZ eyetrial5 papers (2019–2021)Matthis Synofzik · Hertie Institute for Clinical Brain Research5 papers (2019–2021)Stéphane Thobois · Université Claude Bernard Lyon 15 papers (2013–2023)Jonathan Baets · University of Antwerp4 papers (2019–2021)Giovanni Stevanin · Assistance Publique – Hôpitaux de Paris4 papers (2019–2022)David Devos · Alliance for Clinical Trials in Oncology4 papers (2020–2022)Matthis Synofzik · University of Antwerp4 papers (2013–2023)Emmanuel Roze · Centre National de la Recherche Scientifique4 papers (2018–2022)Lüdger Schöls · German Center for Neurodegenerative Diseases4 papers (2013–2023)Emmanuel Broussolle · Université Claude Bernard Lyon 13 papers (2013–2020)Filippo Maria Santorelli · Fondazione Stella Maris3 papers (2020–2021)Cyril Goizet · Centre National de la Recherche Scientifique3 papers (2020–2022)Christine Tranchant · Elsevier, Inc.3 papers (2022–2025)Cyril Mignot · Marienhospital Osnabrück3 papers (2020–2026)Vincent Laugel · Hôpitaux Universitaires de Strasbourg3 papers (2020–2021)